Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Feb 5;19(3):1821.
doi: 10.3390/ijerph19031821.

Evaluating the Oral-Health-Related Quality of Life of Oral Submucous Fibrosis Patients before and after Treatment Using the OHIP-14 Tool

Affiliations
Randomized Controlled Trial

Evaluating the Oral-Health-Related Quality of Life of Oral Submucous Fibrosis Patients before and after Treatment Using the OHIP-14 Tool

Abdul Bari Memon et al. Int J Environ Res Public Health. .

Abstract

The objective of the present study was to assess the oral-health-related quality of life (OHRQoL) of oral submucous fibrosis (OSMF) patients before and after standard treatment. A convenient sampling technique was used to recruit the clinically diagnosed patients of OSMF (n = 130). Based on the medical treatment, the patients were randomly divided into two study groups (group A and B). The group A patients received submucosal intralesional injections of dexamethasone (2 mL; 4 gm/mL), while group B patients received hyaluronidase (1500 IU). Both the group A and B patients received respective medical therapy biweekly for a period of five weeks. At the follow up visit (6 months), the impact of treatment on OHRQoL was assessed using the Oral Health Impact Profile-14 (OHIP-14). Data were analyzed by a chi-square test for quantitative variables and an independent t-test for qualitative variables. The comparison of all clinical parameters before and after treatment was performed by a paired t-test. The results after treatment showed that there was a significant improvement in all domains of OHIP-14 (p = 0.001) except psychological disability (p = 0.243). In addition, the OHRQoL of patients was significantly improved following the treatment.

Keywords: oral cancer; oral health; oral potentially malignant disorders; oral submucous fibrosis; quality of life.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Distribution of chewing habits according to the treatment groups.

Similar articles

Cited by

References

    1. Patil P.G., Hazarey V., Chaudhari R., Nimbalkar-Patil S. A randomized control trial measuring the effectiveness of a mouth-exercising device for mucosal burning in oral submucous fibrosis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2016;122:713–718. doi: 10.1016/j.oooo.2016.07.026. - DOI - PubMed
    1. Tanwir F., Akhlaq H. Oral submucous fibrosis: A chronic deliberating disease of oral cavity. Iran. J. Pathol. 2011;6:165–172.
    1. Patil P., Hazarey V., Chaudhari R., Nimbalkar-Patil S. Clinical Efficacy of a Mouth-Exercising Device Adjunct to Local Ointment, Intra-Lesional Injections and Surgical Treatment for Oral Submucous Fibrosis: A Randomized Controlled Trial. Asian Pac. J. Cancer Prev. 2016;17:1255–1259. doi: 10.7314/APJCP.2016.17.3.1255. - DOI - PubMed
    1. Regezi J., Sciubba J., Jordan R. In: Oral Pathology: Clinical Pathologic Correlations. Dolan J., editor. Elsevier; Amsterdam, The Netherlands: 2016.
    1. Jontell M., Holmstrup P., Ship J. Red and white lesions of the oral mucosa. Burket’s Oral Med. 2008;1:77–78.

Publication types

MeSH terms

LinkOut - more resources